Cross border M&A: the Co-Managing Partner Luigi Santa Maria together with Partner Francesca Torricelli, Senior Associate Elisabetta Nicoli, and Trainee Andreas Fiore assisted a Lux Company in (i) the sale of 100% of LDO share capital to Opocrin S.p.A. (an Italian pharmaceutical company), together with its controlled companies (Italian, Luxemburg, Mexican and Chinese), and (ii) in its re-investment in the Company of the Buyer (an Italian pharmaceutical company), which has been realized both by means of equity and hybrid instruments subscription.
Click here to read the full article in legalcommunity titled "Opocrin acquisisce Laboratori Derivati Organici: tutti gli studi legali."